Literature DB >> 10362029

Association of fatigue with an acute phase response in sarcoidosis.

M Drent1, R M Wirnsberger, J de Vries, M P van Dieijen-Visser, E F Wouters, A M Schols.   

Abstract

The pathophysiological explanation for fatigue, one of the most common symptoms in sarcoidosis, still has to be elucidated. It was hypothesized that the presence of fatigue is associated with an acute phase response in sarcoidosis. A cross-sectional study was performed in 38 sarcoidosis patients. Resting energy expenditure (REE) was measured in the fasting state by indirect calorimetry using a ventilated hood and adjusted for fat-free mass (FFM). Patients with fatigue (n=25) also suffered more frequently from other symptoms, such as exercise intolerance (p=0.01), the need for sleep (p=0.02) and weight loss (p=0.01), compared to those without fatigue (n=13). However, no relationship was found between fatigue and serum angiotensin-converting enzyme (sACE) or lung function impairment. Patients with fatigue had higher levels of C-reactive protein (CRP) (11.4+/-6.8 microg x mL(-1), p<0.0001) and REE adjusted for FFM (33.0+/-3.7 kcal x kg FFM(-1), p<0.003) compared to those without fatigue (3.2+/-2.2 mg x mL(-1); 29.2+/-2.8 kcal x kg FF(-1)). Furthermore, REE/FFM was significantly related to CRP (r=0.54, p=0.001). This study confirms the presence of an acute phase response as indicated by metabolic derangements and a moderate increase in C-reactive protein levels in sarcoidosis, particularly in those patients with constitutional symptoms. Future studies should focus on the clinical relevance and therapeutic implications of these findings.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362029     DOI: 10.1034/j.1399-3003.1999.13d03.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  16 in total

1.  Fatigue in the Danish general population. Influence of sociodemographic factors and disease.

Authors:  T Watt; M Groenvold; J B Bjorner; V Noerholm; N A Rasmussen; P Bech
Journal:  J Epidemiol Community Health       Date:  2000-11       Impact factor: 3.710

2.  Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status.

Authors:  M A Spruit; M J Thomeer; R Gosselink; T Troosters; A Kasran; A J T Debrock; M G Demedts; M Decramer
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

Review 3.  Patient reported outcome measures (PROMs) in sarcoidosis.

Authors:  Rikke Flor Thunold; Anders Løkke; Adam Langballe Cohen; Hilberg Ole; Elisabeth Bendstrup
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

4.  Progression of airway dysplasia and C-reactive protein in smokers at high risk of lung cancer.

Authors:  Don D Sin; S F Paul Man; Annette McWilliams; Stephen Lam
Journal:  Am J Respir Crit Care Med       Date:  2005-12-09       Impact factor: 21.405

Review 5.  The Clinical Features of Sarcoidosis: A Comprehensive Review.

Authors:  Marc A Judson
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

6.  An erosive lesion in the orbital apex as the presenting sign of sarcoidosis.

Authors:  David Nasrazadani; Anjulie K Quick; William A White
Journal:  Digit J Ophthalmol       Date:  2017-03-04

7.  The six-minute walk test in patients with pulmonary sarcoidosis.

Authors:  Esam H Alhamad
Journal:  Ann Thorac Med       Date:  2009-04       Impact factor: 2.219

8.  Exercise capacity, muscle strength, and fatigue in sarcoidosis: a follow-up study.

Authors:  Rik G J Marcellis; Antoine F Lenssen; Stephan Kleynen; Jolanda De Vries; Marjolein Drent
Journal:  Lung       Date:  2013-04-05       Impact factor: 2.584

9.  Handgrip performance in relation to self-perceived fatigue, physical functioning and circulating IL-6 in elderly persons without inflammation.

Authors:  Ivan Bautmans; Ellen Gorus; Rose Njemini; Tony Mets
Journal:  BMC Geriatr       Date:  2007-03-01       Impact factor: 3.921

Review 10.  Musculoskeletal involvement in sarcoidosis.

Authors:  Akasbi Nessrine; Abourazzak Fatima Zahra; Harzy Taoufik
Journal:  J Bras Pneumol       Date:  2014 Mar-Apr       Impact factor: 2.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.